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Cancer is a heterogeneous disease consisting of many subtypes that usually have both shared and 
distinguishing mechanisms. To derive good subtypes, it is essential to have a computational model that 
can score their homogeneity from different angles, for example, mutated pathways and gene expression. 
In this paper, we introduce our ongoing work which studies a constraint-based optimisation model to 
discover patient subtypes as well as their perturbed pathways from mutation, transcription and 
interaction data. We propose a way to solve the optimisation problem based on constraint programming 
principles. Experiments on a TCGA breast cancer dataset demonstrate the promise of the approach.   
INTRODUCTION 
Discovering patient subtypes and understanding their 
mechanisms are essential to provide precise treatments 
to patients. There have been efforts to understand how 
mutation causes subtypes such as the work by Hofree 
et al., (2013). However, to the best knowledge of the 
authors, it is still an open question on how to combine 
mutation and expression data to derive good subtypes. 
Therefore, we study a new computation model that 
can discover subtypes as well as their specific mutated 
genes and expressed genes from mutation, 
transcription and interaction data. 
METHODS 
We conjecture that a subtype consists of a number of 
patients who have the same set of differentially 
expressed genes and a set of mutated genes that hit the 
same pathways. 
To find both mutations and expressions of patient 
subtypes, we extend our recent ranked tiling method 
(Le Van et al., 2014). Ranked tiling is a data mining 
method proposed to mine regions with high average 
rank values in a rank matrix. In this type of matrix, 
each row is a complete ranking of the columns. We 
find that rank matrices are a good abstraction for 
numeric data and are useful to integrate datasets that 
are at different scales. 
To apply the ranked tiling method, we first transform 
the given numeric expression matrix, where rows are 
expressed genes and columns are patients, into a 
ranked expression matrix. Then, we search for a 
region in the transformed matrix that has high average 
rank scores. However, different from the ranked tiling 
method, we impose a further constraint that the 
columns (patients) of the region should also have a 
number of mutated genes that have high rank scores in 
a network with respect to a network model. We 
formalise this as a constraint optimisation problem and 
use a constraint solver to solve it. 
RESULTS & DISCUSSION 
We apply our method on TCGA breast cancer dataset 
and discover eight subtypes. Compared to PAM50 
annotations, our method divide the Basal subtype into 
three sub-groups named S2, S3 and S6. The LumA 
subtype is divided into 04 smaller groups, namely, S1, 
S4, S7 and S8. Finally, our method could recover the 
Her2 subtype in S5. 
To validate the mined subtypes in the patient 
dimension, we assume PAM50 annotations are true 
labels for them. Then, grouping patients into subtypes 
can be seen as a multi-class prediction problem, for 
which we can calculate F1 score to measure the 
average accuracy. We also compare our scores with 
state-of-the-art, including iCluster+ (Mo, Q. et al., 
2013), NBS (Hofree et al., 2013) and SNF (Wang B. 
et al., 2014). The result (not shown) illustrates that our 
subtypes are more homogeneous than the ones 
produced by iCluster+ and NBS and are comparable to 
those by SNF. 
To validate the mined subtypes in the gene dimension, 
we perform hypergeometric tests to see how their 
mutated genes and expressed genes are related to 
cancer pathways. The figure below is the heatmap 
showing the log_10 p-values of the tests. In this Figure, 
we can see that the discovered subtypes have specific 
perturbed pathways. 
 
 
 
FIGURE 1. Cancer pathway enrichment analysis using 
mined mutated genes and expressed genes of subtypes 
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